A fast track influenza virus vaccine produced in insect cells (Q30226454)

11 June 2017

1 reference

title

A fast track influenza virus vaccine produced in insect cells (English)

1 reference

11 June 2017

0 references

Yoshifumi Hashimoto

2

1 reference

11 June 2017

Manon M. J. Cox

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21784229

7 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21784229

7 December 2024

publication date

1 July 2011

1 reference

11 June 2017

July 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21784229

full work available at URL

7 December 2024

https://api.elsevier.com/content/article/PII:S0022201111000760?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

https://api.elsevier.com/content/article/PII:S0022201111000760?httpAccept=text/plain

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Journal of Invertebrate Pathology

7 December 2024

published in

1 reference

11 June 2017

volume

107 Suppl

1 reference

11 June 2017

page(s)

S31-41

1 reference

The establishment of two cell lines from the insectspodoptera frugiperda (lepidoptera; noctuidae)

11 June 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1007/BF02615077

Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50–64 years of age☆

1

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Influenza as a zoonosis: how likely is a pandemic?

7 December 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Root cause investigation of a viral contamination incident occurred during master cell bank (MCB) testing and characterization--a case study

7 December 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus

7 December 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus

7 December 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Managing influenza in older patients

7 December 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Cell-based protein vaccines for influenza

7 December 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Production of a novel influenza vaccine using insect cells: protection against drifted strains

7 December 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

FluBlok, a next generation influenza vaccine manufactured in insect cells

7 December 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

FluBlok, a recombinant hemagglutinin influenza vaccine

7 December 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes

7 December 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Inactivated influenza vaccines. 2. Laboratory indices of protection

7 December 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

New approaches to confronting an imminent influenza pandemic.

7 December 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Heterogeneity in the haemagglutinin gene and emergence of the highly pathogenic phenotype among recent H5N2 avian influenza viruses from Mexico

7 December 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant.

7 December 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

FluBlok, a recombinant influenza vaccine

7 December 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Host cell-mediated variation in H3N2 influenza viruses

7 December 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccine (TIV) among persons > or =65 years old

7 December 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Inhibition of virus-induced hemolysis with monoclonal antibodies to different antigenic areas on the hemagglutinin molecule of A/seal/Massachusetts/1/80 (H7N7) influenza virus

7 December 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Influenza pandemics of the 20th century

7 December 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

WHO Study Group on cell substrates for production of biologicals, Geneva, Switzerland, 11-12 June 2007.

7 December 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Biological Transmission of Arboviruses: Reexamination of and New Insights into Components, Mechanisms, and Unique Traits as Well as Their Evolutionary Trends

7 December 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Latent infection of a new alphanodavirus in an insect cell line

7 December 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Development of a novel recombinant influenza vaccine in insect cells.

7 December 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Diversity of errantivirus (retrovirus) sequences in two cell lines used for baculovirus expression, Spodoptera frugiperda and Trichoplusia ni.

7 December 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Arbovirus vaccines; opportunities for the baculovirus-insect cell expression system

7 December 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Thousand litre scale microcarrier culture of Vero cells for killed polio virus vaccine. Promising results

7 December 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Morphological and biochemical characterization of influenza vaccines commercially available in the United Kingdom

7 December 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs

7 December 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Consensus-degenerate hybrid oligonucleotide primers for amplification of distantly related sequences

7 December 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

7 December 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Evidence for host-cell selection of influenza virus antigenic variants

7 December 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin

7 December 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

7 December 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

7 December 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

7 December 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial

7 December 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus.

7 December 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Expression and purification of an influenza hemagglutinin--one step closer to a recombinant protein-based influenza vaccine.

7 December 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Spin-labeling of influenza virus hemagglutinin permits analysis of the conformational change at low pH and its inhibition by antibody

7 December 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Epidemiology and pathogenesis of influenza

7 December 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

Susceptibility of the Sf9 insect cell line to infection with adventitious viruses

7 December 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.JIP.2011.05.003

7 December 2024

Identifiers

1 reference

11 June 2017

1 reference